Sputnik V: WHO Seeks More Data For Granting Emergency Use Listing Status
Hyderabad: The World Health Organisation (WHO) has sought some more data from Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, developer of COVID-19 vaccine Sputnik V to accord Emergency Use Listing status for the jab, PTI reported.
Sputnik V is currently manufactured in India and is sold by Dr Reddy’s Laboratories under the Emergency Use Authorisation route.
According to the WHO website, though several meetings were held as part of the process for EUL, the status of the assessment column says, “On hold, awaiting completion of rolling submission”.
“Anticipated date will be set once all data is submitted and follow-up of inspection observations completed,” WHO said on the decision date for EUL.